Skip to main content
SpringerLink
Log in

Endemicity, Diagnosis and Treatment of Schistosomiasis in China

  • Chapter
  • First Online:
Tropical Diseases in China

Part of the book series: Public Health in China ((PUBHECH,volume 5))

  • 104 Accesses

Abstract

Schistosomiasis is a chronic helminthic infection that establishes a long-term, multi-year relationship with its human host in endemic populations. Acute schistosomiasis can occur in non-immune individuals 14–84 days post exposure to a primary infection or heavy reinfection, especially in high transmission areas. It has an average incubation period of 41.5 days. The symptoms of acute schistosomiasis was first described in Japan more than 100 years ago as Katayama fever. More recently, it is referred to as Katayama syndrome. The outbreak of acute schistosomiasis has a serious impact on an individual’s health and hinders the development of social economics in endemic areas. Effective prevention, early diagnosis, and treatment will significantly decrease the burdens associated with acute schistosomiasis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Li SZ, Luz A, Wang XH, et al. Schistosomiasis in China: acute infections during 2005-2008. Chin Med J (Engl). 2009;122:1009–14.

    PubMed  Google Scholar 

  2. Lin CW, Li XR, Guo YH, et al. Simultaneous giant mucinous cystadenoma of the appendix and intestinal schistosomiasis: ‘case report and brief review’. World J Surg Oncol. 2014;12:385.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Li SZ, Zheng H, Abe EM, et al. Reduction patterns of acute schistosomiasis in the People’s Republic of China. PLoS Negl Trop Dis. 2014;8:e2849.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Zhang LJ, Gao FH, Xu ZM, et al. A cluster analysis of cases of schistosomiasis japonica using retrospective space-time permutation scan statistics. J Pathogen Biol. 2014;9:109–12.

    Google Scholar 

  5. Wang Q, Xu J, Zhang L, et al. Analysis of endemic changes of schistosomiasis in China from 2002 to 2010. Chin J Schisto Control. 2015;27:229–34. (in Chinese)

    CAS  Google Scholar 

  6. Zhao WX, Gao SF. Practical schistosomiasis. Beijing: Renwei Publishing House; 1996. (in Chinese)

    Google Scholar 

  7. Hou XY, MaManus DP, Gray DJ, et al. A randomized, double-blind, placebo-controlled trial of safety and efficacy of combined praziquantel and artemether treatment for acute schistsomiasis japonica in China. Bull World Health Organ. 2008;86:788–95.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Zhan ZW, Chen F, Mao CX, et al. Survey on 732 acute schistosomiasis cases in Yanguan District in Wuchang. Chin J Schisto Control. 1991;3:60. (in Chinese)

    Google Scholar 

  9. Caldas IR, Campi-Azevedo AC, Oliveira LF, et al. Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection. Acta Trop. 2008;108:109–17.

    Article  CAS  PubMed  Google Scholar 

  10. Maizels RM, Pearce EJ, Artis D, et al. Regulation of pathogenesis and immunity in helminth infections. J Exp Med. 2009;206:2059–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Xu J, Peeling RW, Chen JX, et al. Evaluation of immunoassays for the diagnosis of Schistosoma japonicum infection using archived sera. PLoS Negl Trop Dis. 2011;5:e949.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Hosho K, Ikebuchi Y, Ueki M, et al. Schistosomiasis japonica identified by laparoscopic and colonoscopic examination. 2010;22:133–6.

    Google Scholar 

  13. Mahmoud AA. Praziquantel for the treatment of helminthic infections. Adv Int Med. 1987;32:193–206.

    CAS  Google Scholar 

  14. Zhou XN, Wang LY, Chen MG, et al. The public health significance and control of schistosomiasis in China—then and now. Acta Trop. 2005;96:97–105.

    Article  PubMed  Google Scholar 

  15. Li SM, Zhao ZY, Peng ZZ, et al. Evaluation on effect of treatment and assistance to advanced schistosomiasis patients in Hunan Province from 2004 to 2013. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2014;26:362–6. (in Chinese)

    PubMed  Google Scholar 

  16. Zhang LJ, Xu ZM, Qian YJ, et al. Endemic status of schistosomiasis in People’s Republic of China in 2015. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2016;28:611–7. (in Chinese)

    Google Scholar 

  17. Ministry of Health, P.R. China. Manual of schistosomiasis prevention and control. 3rd ed. Shanghai: Shanghai Science and Technology Press; 2000. p. 63–4. (in Chinese)

    Google Scholar 

  18. Reboucas G. Clinical aspects of hepatosplenic schistosomiasis: a contrast with cirrhosis. Yale J Bio Med. 1975;48:369–76.

    CAS  Google Scholar 

  19. Warren KS, Reboucas G. Blood ammonia during bleeding from esophageal varices in patients with hepatosplenic schistosomiasis. N Eng J Med. 1964;271:921–6.

    Article  CAS  Google Scholar 

  20. Bisseru B, Patel JS. Cruveilhier-Baumgarten (C-B) disease. Gut. 1989;30:36–137.

    Article  Google Scholar 

  21. Ross AG, Sleigh AC, Li Y, et al. Schistosomiasis in the People’s Republic of China: prospects and challenges for the 21st Century. Clin Microbiol Rev. 2001;14:270–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. McGarvey ST, Wu GL, Zhang S, et al. Child growth, nutritional status and schistosomiasis japonica in Jiangxi, People’s Republic of China. Am J Trop Med Hyg. 1993;48:547–53.

    Article  CAS  PubMed  Google Scholar 

  23. Nokes C, McGarvey ST, Shiue L, et al. Evidence for an improvement in cognitive function following treatment of Schistosoma japonicum infection in Chinese primary schoolchildren. Am J Trop Med Hyg. 1999;60:556–65.

    Article  CAS  PubMed  Google Scholar 

  24. Carvalho ACM, Horwith M. Hepatosplenic schistosomiasis mansoni associated with retarded growth and sexual development: endocrine evaluation. Gas Med Bahia. 1972;72:69–84.

    Google Scholar 

  25. Ross AGP, Li YS, Sleigh AS, et al. Epidemiologic features of Schistosoma japonicum among fishermen and other occupational groups in the Dongting Lake region (Hunan Province) of China. Am J Trop Med Hyg. 1997;57:302–8.

    Article  CAS  PubMed  Google Scholar 

  26. Bharti AR, Weidner N, Ramamooorthy S. Chronic schistosomiasis in a patient with rectal cancer. Am J Trop Med Hyg. 2009;80:1–2.

    Article  PubMed  Google Scholar 

  27. Ellis MK, Li Y, Hou X, et al. sTNFR-II and sICAM-1 are associated with acute disease and hepatic inflammation in schistosomiasis japonica. Int J Parasitol. 2008;38:717–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Hussain S, Hawass ND, Zaidi AJ. Ultrasonographic diagnosis of schistosomal periportal fibrosis. J Ultrasound Med. 1984;3:449–52.

    Article  CAS  PubMed  Google Scholar 

  29. Pereira LM, Domingues AL, Spinelli V, et al. Ultrasonography of the liver and spleen in Brazilian patients with hepatosplenic schistosomiasis and cirrhosis. Trans R Soc Trop Med Hyg. 1998;92:639–42.

    Article  CAS  PubMed  Google Scholar 

  30. Lambertucci JR, dos Santos Silva LC, Andrade LM, et al. Imaging techniques in the evaluation of morbidity in schistosomiasis mansoni. Acta Trop. 2008;108:209–17.

    Article  PubMed  Google Scholar 

  31. Kardorff R, Olveda RM, Acosta LP, et al. Hepatosplenic morbidity in schistosomiasis japonica: evaluation with Doppler sonography. Am J Trop Med Hyg. 1999;60:954–9.

    Article  CAS  PubMed  Google Scholar 

  32. Olveda DU, Olveda RM, Lam AK, et al. Utility of diagnostic imaging in the diagnosis and management of schistosomiasis. Clin Microbial. 2014;3:142.

    Article  Google Scholar 

  33. Fataar S, Bassiony H, Satyanath S, et al. CT of hepatic schistosomiasis mansoni. Am J Roentgenol. 1985;145:63–6.

    Article  CAS  Google Scholar 

  34. Preidler K, Riepl T, Szolar D, et al. Cerebral schistosomiasis: MR and CT appearance. Am J Neuroradiol. 1996;17:1598–600.

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Passos MC, Silva LC, Ferrari TC, et al. Ultrasound and CT findings in hepatic and pancreatic parenchyma in acute schistosomiasis. Br J Radiol. 2009;82:e145–7.

    Article  CAS  PubMed  Google Scholar 

  36. Silva LCS, Maciel PE, Ribas JGR, et al. Treatment of schistosomal myeloradiculopathy with praziquantel and corticosteroids and evaluation by magnetic resonance imaging: a longitudinal study. Clin Infec Dis. 2004;39:1618–24.

    Article  CAS  Google Scholar 

  37. Wu F, Xie Z, Yuan S, et al. Studies on the diagnosis of schistosomiasis with IHA. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 1991;3:138–40. (in Chinese)

    Google Scholar 

  38. Hua W, Zhu Y, He W, et al. Analysis of fraction antigens of soluble egg antigen (SEA) of Schistosoma japonicum. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 1996;8:274–6. (in Chinese)

    Google Scholar 

  39. Zhu Y, Hua W, Liu Y, et al. A study on evaluation of efficacy of chemotherapy for schistosomiasis with fraction antigen of soluble egg antigen of Schistosoma japonicum. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 1996;8:321–4. (in Chinese)

    Google Scholar 

  40. Zhu Y, Socheat D, Bounlu K, et al. Application of dipstick bye immunoassay (DDIA) kit for the diagnosis of schistosomiasis mekongi. Acta Trop. 2005;96:137–41.

    Article  CAS  PubMed  Google Scholar 

  41. Xia CM, Rong R, Lu ZX, et al. Schistosoma japonicum: a PCR assay for the early detection and evaluation of treatment in a rabbit model. Exp Parasitol. 2009;121:175–9.

    Article  CAS  PubMed  Google Scholar 

  42. Wichmann D, Panning M, Quack T, et al. Diagnosing schistosomiasis by detection of cell-free parasite DNA in human plasma. PLoS Negl Trop Dis. 2009;3:e422.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Li YS. Diagnosis and treatment of schistosomiasis. Beijing: People’s Medical Publishing House; 2006. (in Chinese)

    Google Scholar 

  44. Ding SY. Village Doctor’s manual of schistosomiasis prevention and control. Changsha: Hunan People’s Publishing House; 2004. (in Chinese)

    Google Scholar 

  45. Ren GH. Schistosomiasis clinical medicine. Beijing: People’s Medical Publishing House; 2009. p. 388–91. (in Chinese)

    Google Scholar 

  46. Parris V, Michie K, Andrews T, et al. Schistosomiasis japonicum diagnosed on liver biopsy in a patient with hepatitis B co-infection: a case report. J Med Case Rep. 2014;8:45.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Lyra LG, Recouças G, Andrade ZA. Hepatitis B surface antigen carrier state in hepatosplenic schistosomiasis. Gastroenterol. 1976;71:641–5.

    Article  CAS  Google Scholar 

  48. Berhe N, Myrvang B, Gundersen SG. Reversibility of schistosomal periportal thickening/fibrosis after praziquantel therapy: a twenty-six month follow-up study in Ethiopia. Am J Trop Med Hyg. 2008;78:228–34.

    Article  PubMed  Google Scholar 

  49. Moreau R, Durand F, Poynard T, et al. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology. 2002;122:923–30.

    Article  CAS  PubMed  Google Scholar 

  50. Lebrec D, Hillon P, Munoz C, et al. The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study. Hepatology. 1982;2:523–7.

    Article  CAS  PubMed  Google Scholar 

  51. Grace ND, Groszmann RJ, Garcia-Tsao G, et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology. 1998;28:868–80.

    Article  CAS  PubMed  Google Scholar 

  52. Cirera I, Feu F, Luca A, et al. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation. Hepatology. 1995;22:106–11.

    CAS  PubMed  Google Scholar 

  53. Villanueva C, Ortiz J, Minana J, et al. Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding. Gastroenterology. 2001;121:110–7.

    Article  CAS  PubMed  Google Scholar 

  54. Escorsell A, Bandi JC, Andreu V, et al. Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension. Gastroenterology. 2001;120:161–9.

    Article  CAS  PubMed  Google Scholar 

  55. Ottesen LH, Flyvbjerg A, Jakobsen P, et al. The pharmacokinetics of octreotide in cirrhosis and in healthy man. J Hepatol. 1997;26:1018–25.

    Article  CAS  PubMed  Google Scholar 

  56. Luketic VA. Management of portal hypertension after variceal hemorrhage. Clin Liver Dis. 2001;5:677–707.

    Article  CAS  PubMed  Google Scholar 

  57. Westaby D, Macdougall BR, Williams R. Improved survival following injection sclerotherapy for esophageal varices: final analysis of a controlled trial. Hepatology. 1985;5:827–30.

    Article  CAS  PubMed  Google Scholar 

  58. Waked I, Korula J. Analysis of long-term endoscopic surveillance during follow-up after variceal sclerotherapy from a 13-year experience. Am J Med. 1997;102:192–9.

    Article  CAS  PubMed  Google Scholar 

  59. Seewald S, Sriram PV, Naga M, et al. Cyanoacrylate glue in gastric variceal bleeding. Endoscopy. 2002;34:926–32.

    Article  CAS  PubMed  Google Scholar 

  60. D’Amico G, Luca A, Morabito A, et al. Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis. Gastroenterology. 2005;129:1282–93.

    Article  PubMed  Google Scholar 

  61. Bureau C, Garcia-Pagan JC, Otal P, et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology. 2004;126:469–75.

    Article  PubMed  Google Scholar 

  62. Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology. 2005;41:386–400.

    Article  PubMed  Google Scholar 

  63. Seror J, Allouche C, Elhaik S. Use of Sengstaken-Blakemore tube in massive postpartum hemorrhage: aseries of 17 cases. Acta Obstet Gynecol Scand. 2005;84:660–4.

    Article  CAS  PubMed  Google Scholar 

  64. Condous GS, Arulkumarah S. The “tamponade test” in the management of massive postpartum hemorrhage. Obstet Gynecol. 2003;101:767–72.

    CAS  PubMed  Google Scholar 

  65. Yang Z. Surgical strategy of diagnosis and treatment in advanced schistosomiasis. J Surg Concept Pract. 2010;15:301–4. (in Chinese)

    Google Scholar 

  66. Pal S. Current role of surgery in portal hypertention. Indian J Surg. 2012;74:55–66.

    Article  PubMed  Google Scholar 

  67. Zhang Y, Wen TF, Yan LN, et al. Preoperative predictors of portal vein thrombosis after splenectomy with periesophagogastric devascularization. World J Gastroenterol. 2012;18:1834–9.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Winslow ER, Brunt LM, Drebin JA, et al. Portal vein thrombosis after splenectomy. Portal vein thrombosis after splenectomy. Am J Surg. 2002;184:631–5.

    Article  PubMed  Google Scholar 

  69. Gines P, Cardenas A, Arroyo V, et al. Management of cirrhosis and ascites. N Engl J Med. 2004;350:1646–54.

    Article  CAS  PubMed  Google Scholar 

  70. Chen SX. Dwarf subtype of advanced schistosomiasis. In: Ren GH, editor. Schistosomiasis clinical medicine. Beijing: People’s Medical Publishing House; 2009.

    Google Scholar 

  71. Liu JX, Li ZC, Cai DY. Colon proliferative subtype of advanced schistosomiasis. In: Ren GH, editor. Schistosomiasis clinical medicine. Beijing: People’s Medical Publishing House; 2009.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Institute of Parasitic Diseases, Chinese Center for Disease control and Prevention, Shanghai, China

    Jing Xu & Zhi-qiang Qin

  2. Hunan Institute of Parasitic Diseases, Yueyang, China

    Zheng-yuan Zhao, Yong-hui Zhu, Jie Zhou & Zhi-hong Luo

Authors
  1. Jing Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhi-qiang Qin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zheng-yuan Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yong-hui Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jie Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zhi-hong Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jing Xu .

Editor information

Editors and Affiliations

  1. National Institute of Parasitic Diseases, Chinese Centre for Disease Control and Prevention, Shanghai, Shanghai, China

    Xiao-Nong Zhou

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Singapore Pte Ltd. and People's Medical Publishing House, PR of China

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Xu, J., Qin, Zq., Zhao, Zy., Zhu, Yh., Zhou, J., Luo, Zh. (2022). Endemicity, Diagnosis and Treatment of Schistosomiasis in China. In: Zhou, XN. (eds) Tropical Diseases in China. Public Health in China, vol 5. Springer, Singapore. https://doi.org/10.1007/978-981-19-5707-9_2

Download citation

  • DOI: https://doi.org/10.1007/978-981-19-5707-9_2

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-19-5706-2

  • Online ISBN: 978-981-19-5707-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation